Rchr
J-GLOBAL ID:200901022053183427   Update date: Apr. 20, 2024

Nonomura Norio

ノノムラ ノリオ | Nonomura Norio
Affiliation and department:
Research field  (1): Urology
Research keywords  (2): 尿路腫瘍学 ,  Urological malignancies
Research theme for competitive and other funds  (31):
  • 2023 - 2026 腸内細菌叢によるアンドロゲンシグナル経路を介した去勢抵抗性前立腺癌進展機序の解明
  • 2022 - 2026 遺伝的素因、生活習慣、腸内細菌叢の多面的解析に基づく前立腺癌の早期診断戦略の構築
  • 2022 - 2025 尿路上皮癌患者におけるD-アミノ酸発現意義の解明
  • 2022 - 2025 シリコン微細粒子経口投与によるラット異系腎移植モデルにおける免疫応答への効果
  • 2022 - 2025 腎細胞癌局所内免疫状態を構築する血液内細菌叢の同定
Show all
Papers (191):
  • Yujiro Kidani, Yohko Kitagawa, Masaki Hagiwara, Atsunari Kawashima, Takayuki Kanazawa, Hisashi Wada, Motohide Uemura, Norio Nonomura, Daisuke Motooka, Shota Nakamura, et al. Downregulation of TCF7 and LEF1 is a key determinant of tumor-infiltrating regulatory T-cell function. International Immunology. 2024. 36. 4. 167-182
  • Yujiro Kidani, Yohko Kitagawa, Masaki Hagiwara, Atsunari Kawashima, Takayuki Kanazawa, Hisashi Wada, Motohide Uemura, Norio Nonomura, Daisuke Motooka, Shota Nakamura, et al. Downregulation of TCF7 and LEF1 is a key determinant of tumor-infiltrating regulatory T-cell function. International immunology. 2024. 36. 4. 167-182
  • Gaku Yamamichi, Taigo Kato, Tadashi Watabe, Koji Hatano, Motohide Uemura, Norio Nonomura. Current Status of Prostate-specific Membrane Antigen-targeted Alpha Radioligand Therapy in Prostate Cancer. Anticancer research. 2024. 44. 3. 879-888
  • Makishi Nakamura, Kazuaki Yamanaka, Taigo Kato, Koji Hatano, Yoichi Kakuta, Atsunari Kawashima, Shinichiro Fukuhara, Norio Nonomura. A retroperitoneal primary undifferentiated pleomorphic sarcoma. Urology case reports. 2024. 53. 102664-102664
  • Naoki Tsuchiya, Koichiro Kimura, Ukihide Tateishi, Tadashi Watabe, Koji Hatano, Motohide Uemura, Norio Nonomura, Akinobu Shimizu. Detection support of lesions in patients with prostate cancer using [Formula: see text]-PSMA 1007 PET/CT. International journal of computer assisted radiology and surgery. 2024
more...
MISC (113):
  • Sohei Kuribayashi, Shinichiro Fukuhara, Go Tsujimura, Takahiro Imanaka, Koichi Okada, Norichika Ueda, Kentaro Takezawa, Shigeyoshi Saito, Yusuke Takahashi, Hidetaka Kioka, et al. A NOVEL AND FEASIBLE METHOD FOR QUANTIFYING TESTICULAR SPERAMATOGENESIS BY USING CREATINE CHEMICAL EXCHANGE SATURATION TRANSFER IMAGING. JOURNAL OF UROLOGY. 2023. 209. E5-E6
  • Norichika Ueda, Go Tsujimura, Takahiro Imanaka, Sohei Kuribayashi, Koichi Okada, Kentaro Takezawa, Shinichiro Fukuhara, Norio Nonomura. THE EFFECT OF TESTOSTERONE REPLACEMENT THERAPY ON LOWER URINARY TRACT SYMPTOMS. JOURNAL OF UROLOGY. 2023. 209. E1071-E1072
  • Koihic Okada, Takahiro Imanaka, Sohei Kuribayashi, Yosuke Sekii, Kentaro Takezawa, Shinichiro Fukuhara, Hiroshi Kiuchi, Norio Nonomura. THE DIVERSITY OF PROSTATIC MICROBIOTA IS ASSOCIATED WITH PROSTATE ENLARGEMENT. JOURNAL OF UROLOGY. 2022. 207. 5. E269-E269
  • Yosuke Sekii, Hiroshi Kiuchi, Takahiro Imanaka, Sohei Kuribayashi, Koichi Okada, Kentaro Takezawa, Shinichiro Fukuhara, Norio Nonomura. OXIDATIVE STRESS DRIVES NOCTURNAL POLYURIA VIA INTRARENAL SPAK-NCC PATHWAY: A THERAPEUTIC POTENTIAL OF A NOVEL ANTIOXIDANT, SILICON COMPONENT AGENTS. JOURNAL OF UROLOGY. 2022. 207. 5. E857-E857
  • Taigo Kato, Kazuma Kiyotani, Akinaru Yamamoto, Toshihiro Uemura, Gaku Yamamichi, Eisuke Tomiyama, Yoko Koh, Makoto Matsushita, Koji Hatano, Atsunari Kawashima, et al. Early dynamics of T cell clonotypes as potential surrogate biomarker for immune checkpoint inhibitors. CANCER SCIENCE. 2022. 113
more...
Books (1):
  • Proliferation of Shionogi carcinoma cells caused by androgen-induced fibroblast growth factor (FGE)-like peptide in an autocrine mechanism.
    Perspectives in Andrology M. Serio(ed). New York, Raven Press. 1989
Professional career (1):
  • (medical)doctor (Osaka University)
Association Membership(s) (7):
アメリカ癌学会(American Association for Cancer Research) ,  日本透析医学会 ,  日本アンドロロジー学会 ,  日本癌治療学会 ,  日本内分泌学会 ,  日本癌学会 ,  日本泌尿器科学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page